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Abstract
Iodine deficiency during pregnancy and lactation could expose the infant to severe
iodine deficiency disorders. A randomized supplementation trial among rural lactating
women was conducted in Sidama zone, southern Ethiopia, to compare the methods of
iodine delivery on breast milk iodine, and on maternal and infant urinary iodine concentrations. Women were randomly assigned either to receive 225 μg iodine as potassium iodide capsule daily for 6 months or 450 g of appropriately iodized salt (30–40 μg I
as KIO3/g of salt) weekly for household consumption for 6 months. Breast milk iodine
concentration (BMIC) and maternal and infant urinary iodine concentration (UIC) were
measured at baseline and at 6 months. The women did not differ in BMIC and UIC, and
infants did not differ in UIC in a time by treatment interaction. Median (IQR, interquartile range, IQR) BMIC at baseline was 154 [43, 252] μg/L and at 6 months was 105 [36,
198] μg/L, maternal UIC at baseline was 107 [71, 161] μg/L and at 6 months was 130
[80, 208] μg/L; infant UIC at baseline was 218 [108, 356] μg/L and at 6 months was
222 [117, 369] μg/L. Significant correlations among the three variables were obtained
in both groups at both times. We conclude that for lactating women an adequate
amount of appropriately iodized salt (30–40 μg I/g) had similar effects as a daily supplement of 225 μg I on BMIC and on maternal and infant UIC.
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1 | INTRODUCTION

infant morbidity and mortality (Zimmermann, 2009). Infants under two
years of age are among the most vulnerable groups to be affected by

Iodine is required for the synthesis of thyroid hormones; thyroid hor-

iodine deficiency along with pregnant and lactating mothers (WHO/

mones in turn regulate the metabolic patterns of cells. Iodine plays a

UNICEF 2007). Hence, special attention is needed for these population

crucial part in the process of early growth and development of most

groups regarding preventing and controlling iodine deficiency (Delange,

organs, especially the brain (Chan & Kilby, 2000). Severe maternal io-

2004).

dine deficiency during early pregnancy could result in permanent brain

Risk of iodine deficiency in early infancy is high even in iodine

damage to the offspring (Halpern et al., 1991; Pharoah, Buttfield, &

sufficient areas because infant intrathyroidal reserve turnover rate

Hetzel, 1971). Mild-to-moderate iodine deficiency may result in re-

is rapid (Delange, 1998). Therefore, in iodine insufficient areas, rec-

duced learning ability, and increased risk of low birth weight and of

ommendations for iodine for women during pregnancy and lactation
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are increased to 250 μg/day or to a 400 mg single annual dose of
iodized oil supplement (Andersson, de Benoist, Delange, & Zupan,
2007). Because a large amount of iodine is secreted into breast milk,
exclusively breastfed infants 0–6 months of age should receive suf-
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2 | MATERIALS AND METHODS
2.1 | Data source and study population

ficient iodine through breast milk (Delange, 2004; Spitzweg, Joba,

The study was conducted in rural areas of Sidama zone, southern

Eisenmenger, & Heufelder, 1998).

Ethiopia. All lactating women (n = 101) in the randomly selected

Recommended intakes for infants are based on mean iodine intake

study villages who delivered between January and February, 2013

of healthy full-term infants fed breast milk, because functional criteria

were recruited within a week after delivery to participate in the

that reflect iodine intake in infants are not available. Hence, the WHO

study. Informed consent was obtained from the women for them-

recommends daily intake of iodine for infants as 90 μg (WHO/UNICEF/

selves and for their infants. This study was conducted in accordance

ICCIDD 2007). Similarly, the Institute of Medicine (IOM) in the USA set

with the ethical principles for the protection of human subjects.

the adequate iodine intake for infants 0–6 months of age at 110 μg/

Ethical approval was obtained from Oklahoma State University

day. This recommendation is based on two important points. First, the

(OSU), USA, Hawassa University, Ethiopia, and the Ministry of

median breast milk iodine concentration (BMIC) in the United States

Science and Technology, Ethiopia. The study was a randomized in-

was 146 μg/L (Institute of Medicine 2001). Second, based on the esti-

tervention trial.

mated daily breast milk excretion, the mean amount of iodine obtained

Mother-infant dyads were assigned using random numbers to re-

by an infant from 0.78 L of human milk is approximately 115 μg/day

ceive either 225 μg of iodine as potassium iodide in capsule form (Pure

(Institute of Medicine 2001). Iodine intake greater than the require-

Encapsulations, Inc. Boston, MA) administered to the mother daily for

ment generally will be excreted in the urine (Zimmermann, 2007).

6 months or 450 g (30–40 μg of I as KIO3/g of salt) of iodized salt (I-

BMIC can be increased by increasing maternal iodine intake
(Zimmermann, 2007). In a study in 16 healthy lactating US women, the

salt) delivered weekly for household consumption for 6 months.
Mean iodine concentration of the salt manufactured for this re-

BMIC was significantly increased by a one-time ingestion of 600 μg

search project was verified by inductively coupled plasma mass spec-

potassium iodide (456 μg of iodine) with peak levels at 6 hr (Leung,

trophotometry (ICP-MS, Elan 9000, Perkin-Elmer, Norwalk, CT) to be

Braverman, He, Heeren, & Pearce, 2012). In a randomized, double-

35.1 (3.6) μg/g, consistent with the recommendation (20–40 mg of

blind, placebo-controlled study, supplementation to lactating women

iodine per kg of salt) of international organizations (WHO/UNICEF/

of either 75 μg/day or 150 μg/day of iodine as potassium iodate for

ICCIDD 1996, 2007). The dose of 225 μg of iodine capsule adminis-

6 months significantly increased the BMIC and maternal urinary io-

tered daily was at the lower end of the recommended range for lactat-

dine concentration (UIC). However, the amount of supplementation

ing women (225–350 μg daily) (Delange, 2007).

given was not sufficient to improve the mothers’ or infants’ thyroid

Capsules were administered to the mothers daily by health exten-

hormones (Mulrine, Skeaff, Ferguson, Gray, & Valeix, 2010). In an-

sion workers or salt for the household was delivered in a sealed plastic

other double-blind, randomized, placebo-controlled trial, one dose of

bag weekly. The amount of salt remaining at the end of the first week

400 mg of iodine as a capsule of iodized poppy seed oil to lactating

was weighed to estimate per capita consumption and the mean was

mothers significantly increased the UIC of their 3-month-old infants

10.3 (2) g. Women were strictly reminded every week not to buy or

compared with a single dose of 100 mg iodine given orally as an io-

use salt from the local market until the end of the study and not to

dized oil supplement directly to the infants (Bouhouch et al., 2014).
As a strategy to alleviate iodine deficiency, increasing iodine intake
through supplementation or food fortification has been recommended.

share the salt we gave them with anybody outside their household.
However, the culture of valuing and sharing salt may have reduced the
amount of leftover salt reported.

Salt iodization programs have been found to be most useful because
they are cost-effective and feasible, and salt is consumed by almost
everyone (WHO/UNICEF/ICCIDD 2007). In places where salt iodiza-

2.2 | Anthropometry and questionnaire

tion is not feasible and/or is unavailable, iodine supplements should

Weight (kg) and height (cm) of mothers were measured to calculate

be given to at-risk groups including pregnant or lactating women and

body mass index (BMI = weight (kg)/height (m)2). Weight was meas-

infants (Andersson et al., 2007).

ured on a solar digital scale (Uniscale, UNICEF, NY) and recorded to

Previous studies in rural Sidama reported median UIC of 15 μg/L

the nearest 100 g and height was measured to the nearest 0.1 cm

in pregnant women (Ersino, Tadele, Bogale, Abuye, & Stoecker, 2013)

using a single calibrated instrument (Adult Board, Schorr Productions,

and 37 μg/L in reproductive age women (Gebreegziabher et al., 2013).

Olney, MD). Mid upper arm circumference (MUAC) was measured to

Our study was designed and approved before Ethiopia’s salt iodization

the nearest 0.1 cm using a non-stretchable plastic measuring tape. A

legislation was enacted. Once the legislation was passed, program im-

pre-tested questionnaire was administered to assess the socioeco-

plementation was rapid and the population began to have access to

nomic and demographic characteristics including household size of

iodized salt. Thus, our study with lactating women compared the effi-

the mothers participating in the study.

cacy of appropriately iodized household salt to daily intake of iodine

Before delivery of supplements, baseline data including anthro-

capsules in raising the BMIC and maternal and infant UIC in a context

pometry, urine samples, breast milk samples, and sociodemographic

of villagers already having some access to iodized salt.

information were collected from mothers. Infant urine samples also
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were obtained. Following 6 months of supplementation, the same bio-

diluted with 2% NH3OH (Sigma-Aldrich, St. Louis, MO) in deionized

logical samples were collected from mothers and their infants.

water and tellurium was utilized as an internal standard.
Drinking water samples were collected from each of the study

2.3 | Biochemical measurements
2.3.1 | Breast milk iodine
Ten mL of breast milk was collected from each mother in plastic

villages. Water iodine concentration was analyzed using the same
method as UIC.

2.6 | Statistical analysis

cups and stored in tightly capped vials. Breast milk samples were

The primary outcome variables in this study were the BMIC and ma-

collected between 9:00 and 11:00 AM. Samples were frozen until

ternal and infant UIC. All data were checked for normality using the

they are analyzed. To extract iodine from the breast milk 1.5 mL

Kolmogorov-Smirnov test and skewed data were log transformed be-

of 25% tetramethylammonium hydroxide (TMAH) solution (Sigma-

fore analyses.

Aldrich, St. Louis, MO) and 0.5 mL of 30% hydrogen peroxide were

The PROC MIXED command was used for linear mixed model

added to the breast milk samples (3 mL) and mixed well. These sam-

analysis to assess the effect of the two methods of iodine supplemen-

ples were incubated in an oven at 90°C for 3 hr using DigiTUBES

tation at 6 month. The model tested treatment (between groups) and

(Perkin-Elmer, Waltham, MA). After cooling to room tempera-

time (within groups) and treatment * time interaction.

ture, the samples were centrifuged at 1,532 x g for 15 minutes.

Associations between outcome variables were assessed using

For analysis, all breast milk samples were diluted 25-fold with 5%

Spearman’s correlation analysis. The relation between multiple vari-

TMAH (Sigma-Aldrich, St. Lowis, MO) in deionized water. BMIC

ables and infant UIC were modeled using stepwise linear regression.

was analyzed by ICP-MS (Fecher, Goldmann, & Nagengast, 1998).

Data are reported as mean (SD), median with interquartile range

Tellurium (Perkin-Elmer Life and Analytical Sciences, Shelton, CT)

[IQR], or frequency (%) as appropriate. Significance was set at p < .05.

was utilized as an internal standard. Non-fat milk powder (RM 1549,

SPSS (version 20; IBM Corp. Armonk) and SAS (Version 9.3; SAS

National Institute of Standards and Technology, Gaithersburg, MD)

Institute Inc., Cary, NC) were used for data analyses.

was used as an external control. The reference value for the external control was 3.38 ± 0.02 mg I/kg and the measured value was
3.35 ± 0.03 mg/kg.

2.4 | Urinary iodine

3 | RESULTS
3.1 | Characteristics of study participants at baseline
All women breastfed exclusively in the first week after delivery and

Mothers provided fresh urine in a cup from which samples were trans-

continued breast feeding to 6 months. However, only 58% reported

ferred to vials that were then tightly sealed. Urine samples were col-

exclusive breast feeding at the age of 6 months (data not shown). The

lected from infants by placing cotton balls appropriately inside a plastic

mean (SD) times per day of breast feeding in the 24 hr preceding the

sheet available in the local market. The infants were checked every

survey at first week in both groups was 12.8 (5.2) (Table 1).

10 minutes until urine was obtained. Urine samples were collected by

Mother-infant dyads did not differ in any sociodemographic char-

squeezing urine out of the cotton balls. New trace mineral free gloves

acteristics assessed as indicated in Table 1. The median [IQR] age of

were used for each infant to avoid contamination. Moreover, samples

all mothers was 22 [20, 25] years, mean BMI was 21.5 (2.3) kg/m2

of cotton balls and plastic sheets were soaked in deionized water and

and MUAC was 23.3 (1.7) cm. The mean gravidity and parity of all the

the iodine content in the water was assayed. Iodine content in the

mothers were 3 (2) and the mean household size was 6.0 (2.3). Mean

water was below the detection limit of 1 μg/L.

school attendance was 3.8 (3.5) years.

Samples were frozen at −20°C at Hawassa University and then

The median age of infants at baseline was 6 [4, 8] days. There

transported to OSU for analysis. Urinary iodine was diluted in 2%

were 50 male and 51 female infants enrolled in the study. The average

ammonium hydroxide and analyzed by ICP-MS, with tellurium as in-

household salt use per week was 440 (2) g and no household reported

ternal standard (Caldwell et al., 2003). Quality control samples for

using less than 435.5 g during the first week.

urinary iodine were measured every 10 samples to ensure stability
of the instrument. Urinary creatinine was analyzed using a BioLis 24i
clinical chemistry analyzer with standard reagents (Carolina Liquid
Chemistries Corp., Brea, CA).

3.2 | Breast milk and urinary iodine concentration of
mothers and their infants
Table 2 shows baseline and 6 months concentrations and distribu-

2.5 | Salt and drinking water iodine concentration
A 10 g salt sample was collected at baseline in a tightly sealed plastic

tions of BMIC and of UIC of mothers and their infants. The women
were not significantly different in BMIC or UIC by treatment and
the infants were not significantly different in the UIC at the two

bag from each household for iodine content analysis. Salt iodine con-

time points for either treatment. To better understand effects of

centration (SIC) was analyzed using ICP-MS. A salt sample (1 gm) was

daily iodine supplementation, we categorized BMIC into different

924
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T A B L E 1 Socio-demographic and anthropometric characteristics
of mother-infant dyads at baseline (n = 101)

tating women, 47.5% and 38.6% of the women had UIC < 100 μg/L at

Capsule
group (n = 50)

of the women had UIC below 50 μg/L and 10% were below 50 μg/L

I-Salt group
(n = 51)

According to the WHO classification for iodine deficiency in lacbaseline and at 6 months, respectively. Furthermore, at baseline 11%

p-value

at 6 months. Maternal UIC showed no time by treatment interaction

Mothers
Age (years)

23 [20, 27]

21 [20, 25]

.14

MUAC (cm)

23.2 (1.8)

23.3 (1.7)

.62

2

21.2 (2.5)

21.8 (2.0)

.15

BMI (kg/m )

(p = .668). Also, maternal UIC adjusted for creatinine was not significantly different between groups or over time (p = .748).
The proportion of infants with the UIC < 100 μg/L at baseline was
20.8% and at 6 months was 15.8%. The median UIC of infants was

Gravidity

2 [1.75, 4]

2 [1, 5]

.41

Parity

2 [1, 4]

2 [1, 4]

.38

School years

2 [2, 3]

2 [1, 3]

.42

Household salt iodine concentration collected at baseline showed

Household size

6 (2.6)

5.7 (2.0)

.94

high variation (0–42 μg/g) with a median [IQR] of 8.1 [4.3, 13.4] μg/g.

Frequency of breast
feeding yesterday
(night hours)

6.7 (2.5)

6.4 (3.1)

.35

Frequency of breast
feeding yesterday
(daylight hours)

6.5 (2.5)

not significantly different in time by treatment interaction (p = .322)
(Table 2).

Among the salt samples tested 21% met the minimum recommendation (15 μg/g) (WHO/UNICEF/ICCIDD 2001) for iodine adequacy

6.0 (3.1)

.28

(Data not shown). Drinking water iodine concentration was below the
detection limit of 1 μg/L.
Relations between BMIC, maternal UIC and infant UIC at 6 months
were examined (Data not shown). BMIC was significantly correlated

Infants
Age (days)

5 [3, 7]

6 [5, 8]

Sex

.06
.765

Male

48% (24/50)

51% (26/51)

Female

52% (26/50)

49% (25/51)

with maternal UIC (r = .39, p < .001) and infant UIC (r = .44, p < .001).
The correlation between BMIC and maternal UIC increased when maternal UIC was adjusted for creatinine (r = .51, p < .001). Maternal UIC
was correlated with infant UIC (r = .31, p < .001). The correlation coefficients at baseline were similar to those at 6 months.

Data are median [IQR], mean (SD), % (n/N). Group mean difference was
analyzed using T-test or Mann-Whitney U test, and the categorical variable
(sex) was analyzed using the Chi-square test, p < .05 was considered
significant.

In Table 3, multiple regression models with four best-fitting variables predicting infant UIC are presented. The model at baseline with
all four predictors produced an adjusted R2 = .290 and at 6 months
the model adjusted R2 was .316. At baseline maternal UIC/creatinine,

groups. At the end of the study at 6 months 36% of the women had

BMIC and infant sex had significant regression weights, indicating

BMIC < 60 μg/L, 18% had 60–120 μg/L, 29% had 120–240 μg/L

infants whose mothers had higher maternal UIC and BMIC were ex-

and 16% had >240 μg/L. BMIC was lower at 6 months than at

pected to have higher UIC and female infants were expected to have

baseline but there was no significant time by treatment interaction

lower UIC than males. At 6 months maternal UIC/creatinine and BMIC

(p = .656).

had significant regression weights, indicating that higher maternal UIC

Capsule group
Mothers
BMIC (μg/L)b
BMIC < 120 (μg/L)

c

UIC (μg/L)

I-salt group

Baseline

6 months

Baseline

6 months

149 [46, 266]

104 [39, 197]

157 [29, 243]

111 [34, 202]

40%

56%

39%

53%

136 [76, 173]

150 [86, 220]

95 [64, 142]

110 [73, 191]

UIC < 100 (μg/L)

42%

32%

53%

45%

I/Cre (μg/g)

214 [142, 292]

176 [126, 383]

203 [139, 268]

173 [117, 292]

234 [121, 379]

254 [130, 400]

193 [107, 331]

195 [108, 352]

40%

38%

49%

47%

16%

8%

18%

24%

Infants
UIC (μg/L)
UIC < 180 μg/L
UIC < 100 μg/L
a

d

Data are median [IQR] or percentage.
BMIC, breast milk iodine concentration; UIC, urinary iodine concentration; Cre, creatinine; I-salt
group, iodized salt group.
c
BMIC ≥ 120 μg/L is assumed to provide the infant’s daily requirement of 90 μg (Zimmermann, 2007).
d
Infant UIC ≥ 180 μg/L represents the expected UIC output in the neonates and infants when the
recommended dietary intake of iodine (225–350 μg/day) for lactating mothers and 90 μg of iodine
daily for neonates and infants are met (Delange, 2007).
b

T A B L E 2 BMIC and UIC of mothers and
infants in subjects who received iodine as a
capsule (n = 50) or iodized salt (n = 51)a
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T A B L E 3 Multiple regression predicting
UIC of infants at baseline and 6 monthsa

At baseline
Variables

β

925

At 6 months

95% CI

p

β

95% CI

p

Maternal UIC/
Creatinine (μg/g)

0.30

0.15, 0.64

.002

0.42

0.26, 0.65

.000

BMIC (μg/L)

0.26

0.05, 0.29

.006

0.27

0.06, 0.28

.003

−0.16

−0.05, 0.003

.083

0.12

−0.01, 0.07

.167

−0.18

−0.24, −0.002

.046

−0.13

−0.19, 0.02

.121

Infant’s age (days)
Female infant

b

Adjusted R-square

0.290

0.316

a

The dependent variable (infant UIC) and the independent variables including maternal UIC/Creatinine
and BMIC were analyzed as log transformed data because they were not normally distributed (n = 101).
b
Infants sex was coded as 0 for Female and 1 for Male.

and higher BMIC were expected to be associated with higher infant

225 μg daily or well-iodized salt weekly for 6 months, median BMIC de-

UIC.

creased from 154 μg/L at baseline to 105 [36, 198] μg/L at 6 months.
Consistent with our study, although the baseline iodine status of the

4 | DISCUSSION

women in New Zealand was lower, Mulrine et al. (2010) found that
BMIC declined over the first 24 weeks in non-supplemented lactating women and supplementation with 75 μg or 150 μg of iodine daily

This study showed BMIC, maternal UIC and infant UIC were not sig-

did not increase BMIC to a level that could raise infant median UIC.

nificantly different between mothers who received 225 μg of iodine

In the women who received 75 μg of iodine for 24 weeks, BMIC

daily as a capsule for 6 months in addition to variable amounts of io-

ranged between 35 to 57 μg/L and median infant UIC was 50 [22,

dine (median 8 [4.3, 13.4] μg/g) in their existing household salt and

60] μg/L. In the group who received 150 μg, BMIC ranged between

mothers who received 450 g per household of appropriately iodized

43 and 70 μg/L and infant UIC was 66 [36, 87] μg/L (Mulrine et al.,

salt (30–40 μg/g) delivered weekly for 6 months.

2010). In another study, BMIC in non-supplemented mothers declined

Average (SD) salt intake in Ethiopia nationally was estimated at 8.4

from 43 μg/L at baseline to 26 μg/L over a 9-month-period while milk

(5.9) g while intakes in the study region were estimated at 17.2 (13.8)

from the mothers supplemented with 400 mg of iodine declined from

g per person per day (Abuye, Berhane, Akalu, Getahun, & Ersumo,

41 μg/L at baseline to 39 μg/L at 9 months (Bouhouch et al., 2014).

2007). One reason the salt intake in this region is high is because peo-

It should be noted that our baseline data were collected within

ple in the rural areas consume salt in their coffee several times a day in

1 week (with more than 32% within 4 days) after delivery, when some

addition to other food items. From our weekly follow up however, the

colostrum was still available. Iodine concentration is high in colostrum

amount of salt we provided (450 g) was reported to be sufficient for

and decreases over time, which could contribute to BMIC decrease

the household for 1 week. The mean amount of salt remaining at the

from baseline to 6 months (Semba & Delange, 2001). On the other

end of the first week was 10.3 g.

hand, volume of milk consumed increases substantially between the

In the current study, the average household size in the I-salt group

first days after birth and 6 months of age, so the total amount of iodine

was 5.7. However, because one of the household members was a new

received by the infant at 6 months would not have decreased (Neville

born infant, who would not be using salted foods, the daily discre-

et al., 1988, WHO 1998). However, because the decrease in iodine

tionary per capita salt intake was 13.7 g based on a household size of

concentration in breast milk over time has not been measured in detail,

4.7. This amount of salt with mean iodine content of 35.1 μg/g would

it is difficult to quantify the effect our supplementation had on the

provide a calculated mean discretionary intake of 481 μg of iodine per

usual decrease in BMIC from colostrum to mature milk.

person per day. Even with cooking losses which have been estimated

A study conducted at a time when only 4.2% of households

at 20%, the iodine intake would exceed the 250 μg daily recommended

in Ethiopia consumed iodized salt reported BMIC in the range of

for lactating women (Delange, 2004, WHO/UNICEF 2007).

5–16 μg/L (Abuye & Kelbessa, 2000). Our data collected after the

Maternal iodine intake is critical during lactation in order to provide

policy that all salt should be iodized showed a wide range in BMIC

the breastfeeding infant’s iodine requirement. Iodine is concentrated

at baseline as well as at 6 months. At baseline, the BMIC ranged

through the sodium iodide symporter mechanism, which promotes in-

from 8 μg/L to 965 μg/L with 40% below 120 μg/L. At 6 months the

creased expression of iodine in milk during lactation (Tazebay et al.,

range was from 4 μg/L to 958 μg/L with 57% below 120 μg/L. Only

2000). Thus, iodine is present in breast milk at higher concentrations

10% of the women had BMIC > 300 μg/L in response to supplemen-

than in plasma (Azizi & Smyth, 2009).

tation. Although there was wide range in both BMIC and UIC, there

The median BMIC (154 [43, 252] μg/L) at baseline was within the

were few concerningly high values in response to either iodized salt

normal range of 150–180 μg/L in iodine sufficient countries (Dorea,

or iodine capsule and no adverse reaction was reported in any of

2002; Semba & Delange, 2001). Despite iodine supplementation of

the study participants. In a study of 50 Korean women, whose diets

926

|

GEBREEGZIABHER

and

STOECKER

frequently included seaweed soup, considerable elevation and range

are expected to produce UIC output in the neonates and infants of

of BMIC from 198 to 8484 μg/L was reported (Rhee, Braverman, Pino,

180–225 μg/L (Delange, 2007). In the current study median UIC of in-

He, & Pearce, 2011). Significant variation of BMIC ranging from 5 to

fants was within the range of this expected output in both groups and

2170 μg/L (Dorea, 2002) and from 9 to 1267 μg/L (Semba & Delange,

at both times. Surprisingly the median UIC of infants obtained in this

2001) were also reported in two other reviews. This variation indicates

study at baseline was relatively high (218 μg/L) compared with data

that many infants may not get adequate amounts of iodine to meet

reported from three of four iodine sufficient countries (Zimmermann,

their requirement while others consume large amounts of iodine with-

2007). However, despite the median UIC of 218 μg/L in our study,

out apparent adverse reaction.

17% of the infants at baseline and 16% at 6 months had UIC below

Maternal median UIC was not significantly different between the

100 μg/L.

two types of iodine supplements. Based on the range recommended

The median infant UIC at baseline was significantly higher than

by Delange (2007), median maternal UIC of 150–230 μg/L as an indi-

BMIC (p < .001) and maternal UIC (p < .001) and, although not sig-

cator for optimal iodine nutrition during pregnancy and lactation, most

nificant, median BMIC tended to be higher than maternal UIC. This

of our study participants in both groups fell below the minimum value

pattern was similar to other studies that reported these variables

at baseline. Following 6 months of iodine supplementation, however,

(Bouhouch et al., 2014; Mulrine et al., 2010). The majority of iodine

most of the women in the capsule group were within the minimum

consumed by lactating women is excreted in the breast milk; infants

range whereas most of the women in the I-salt group remained below

need small amounts to meet their daily requirement, and the remaining

the range.

iodine will be excreted in their urine supporting this pattern (Delange,

For women in our study who had UIC > 100 μg/L, which also has

2007; Zimmermann, 2007).

been considered adequate for lactating women, 16% at baseline and

The correlation between maternal UIC and BMIC increased

29% at 6 months had BMIC < 120 μg/L, which is the concentration

when maternal UIC was adjusted for creatinine. A study conducted

assumed adequate to cover the infant’s daily requirement of 90 μg

in Denmark likewise reported that urinary iodine predicted the

(Zimmermann, 2007). For all women (n = 101) combined at 6 months,

BMIC more precisely when it was adjusted for creatinine (Andersen,

those mothers with UIC below 150 μg/L (n = 54) had median BMIC of

Moller, & Laurberg, 2014). Another study reported that urinary io-

83 μg/L and above 150 μg/L (n = 47) median BMIC was 133 μg/L. This

dine was not associated with median thyroid stimulating hormone

could indicate that iodine intakes of mothers who had UIC < 150 μg/L

(TSH) and thyroxine (T 4) but was significantly associated when it was

were inadequate to raise iodine status to a level that provided optimal

adjusted for creatinine (Haddow, McClain, Palomaki, & Hollowell,

breast milk iodine for the infant.

2007).

The median maternal UIC of 107 μg/L at baseline indicated an im-

In our regression model for infant UIC at baseline, maternal uri-

provement in the iodine status of the population compared with prior

nary iodine adjusted for creatinine and BMIC were positive predic-

years because Ethiopia, including the study population, has been mod-

tors and being female was a negative predictor. At 6 months maternal

erately to severely iodine deficient for decades (Median UIC in stud-

urinary iodine adjusted for creatinine and BMIC were strong positive

ies conducted in southern Ethiopia between 2007 and 2010 ranged

predictors.

between 1 μg/L to 89 μg/L) (Abuye & Kelbessa, 2000; Bogale et al.,

We did not analyze iodine content of complementary foods.

2009; Ersino et al., 2013; Gebreegziabher et al., 2013; Girma et al.,

When complementary feeding is begun, breast milk consumption

2012). Therefore, the higher UIC observed at baseline in this study can

will be reduced and the amount of iodine provided to the infant

be attributed to the salt iodization program that began to be imple-

through breast milk will decrease (WHO 1991). In this study iodine

mented in 2012 in the country (Ethiopian Public Health Institute 2014).

concentration of all of the water samples from different sources was

The proportion of women with UIC below 100 μg/L decreased

below the detection limit of 1 μg/L (Data not shown) predicting low

from 42% to 32% in the capsule group and from 53% to 45% in the

iodine intake in the study area. Because these subsistence farmers

I-salt group between baseline and the end of the study. A double-

do not buy foods from outside, iodized salt is a critical source of

blind, randomized, placebo-controlled study in Morocco reported a

iodine for the study population. As infants begin to get a higher

14% increase in UIC at 6 months after giving the lactating mother a

percent of energy from low iodine complementary foods, their total

400 mg iodized oil capsule (Bouhouch et al., 2014). The study in New

iodine intake will go down. In the study region (Southern Nations,

Zealand showed that a daily supplement of either 75 μg or 150 μg of

Nationalities and Peoples’ Region), the median duration of exclu-

iodine daily for 6 months during lactation increased median maternal

sive breastfeeding was 2.2 months (Central Statistical Agency and

UIC significantly but the median values still remained below 100 μg/L

ICF International 2012), so iodine intake of infants may begin to de-

(Mulrine et al., 2010).

crease early in life.

In the current study, although the UIC increase was not significant,

Unique strengths of the present study were that we recruited all

the proportion of women with the UIC above 100 μg/L was increased

of the women who delivered within the data collection time period

from 58% at baseline to 68% at 6 months in the capsule group and

and compliance was monitored by daily administration of capsules and

from 47% at baseline to 55% at 6 months in the I-salt group.
The recommended dietary intakes (225–350 μg/day) of iodine for
lactating mothers and 90 μg of iodine daily for neonates and infants

weekly delivery of household salt. Unfortunately, obtaining approvals
for the study caused baseline data collection to begin after iodized salt
had begun to reach the market.

GEBREEGZIABHER

and

STOECKER

CONCLUSIONS
In conclusion, our findings suggest that salt iodized at the recommended level (30 – 40 μg I as KIO3/g) provided to the household
had a similar effect on BMIC and maternal and infant UIC as a daily
supplement of 225 μg I as potassium iodide to lactating women. The
iodine concentration of BMIC and UIC obtained in the study participants was comparable to median values in iodine sufficient countries
(Zimmermann, 2007).
As a way to combat iodine deficiency disorders, universal salt
iodization has been recommended. However, it is important to ensure that the salt is homogenously iodized and contains the required
amount of iodine. The salt used in this study was iodized specifically
for research purposes. The salt sold in the Ethiopian market at the time
of the study varied notably in a range of 0–42 ppm (data not shown)
which would result in variable iodine intakes.
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